For this position, the recruiting organisation is the Cyprus Institute of Neurology & Genetics (CING) in Nicosia, Cyprus. CING will employ you and you will be embedded in the POLARIS consortium. Academic supervision and disease-specific expertise will be provided by Prof Kleopa Kleopa and Dr Irene Sargiannidou from the Neuroscience Department.

Cyprus Institute of Neurology & Genetics (CING)
The Cyprus Institute of Neurology & Genetics (CING) was established in 1990 and is a private, bi-communal, non-profit Centre of Excellence based in Nicosia, Cyprus. CING combines its three pillars — specialised healthcare services, research and education — to advance knowledge in neurology, genetics, biomedical and clinical sciences, with the ultimate goal of improving patients’ quality of life.
As part of its education pillar, CING offers accredited postgraduate programmes leading to Master’s and doctoral degrees in areas aligned with the Institute’s scientific and clinical expertise. CING is committed to scientific excellence, innovation, Open Science and research integrity, while fostering an inclusive and supportive research environment.
You will work in the Neuroscience Department, which focuses on the cellular and molecular mechanisms underlying neurological disorders, including inherited neuropathies such as Charcot–Marie–Tooth disease (CMT), multiple sclerosis and leukodystrophies. Through the development of innovative experimental models, the department has advanced the understanding of disease mechanisms in demyelinating disorders.
A major area of research focuses on glial cell biology, with particular emphasis on the role of gap junctions in the peripheral and central nervous systems. The department also develops novel gene therapy strategies aimed at replacing defective connexin genes, with the goal of treating demyelinating diseases affecting the peripheral and central nervous systems.
This doctoral project will first test leading AAV capsids developed by Myrtelle Therapeutics Inc. in the in vitro model. You will assess their effects on myelination and oligodendrocyte survival. The most promising oligodendrocyte-targeting AAV variants will subsequently be tested in a PMLD1 mouse model to determine their therapeutic potential in vivo.
Planned secondments will provide specialised training in establishing isogenic iPSC-derived myelinating organoids under the supervision of Dr Hendrick Rosewich in Tübingen, Germany. You will also have the opportunity to develop experience in patient advocacy, networking and research planning through a placement at the European Leukodystrophy Association (ELA).
The position is based in Nicosia, Cyprus, with academic enrolment through the Graduate School of the Cyprus Institute of Neurology and Genetics. You will pursue a PhD degree in Neuroscience.
Strict eligibility criteria under the Marie Skłodowska-Curie Doctoral Network programme apply:
- At the time of recruitment, you must not already hold a doctoral degree.
- The MSCA mobility rule applies. Because CING is the recruiting organisation for this position, you must not have resided or carried out your main activity, such as work or study, in Cyprus for more than 12 months in the 36 months immediately before the recruitment date.
- You must be able and willing to work in an international training network, participate in network-wide training activities and undertake planned secondments with POLARIS partner organisations.
We are looking for a candidate with a Master’s degree in Life Sciences, preferably in Neuroscience, and a strong interest in translational neuroscience and rare disease research.
Relevant experience may have been gained during an internship, thesis project or other research project. Hands-on experience with in vivo mouse research is essential, while experience with behavioural or neurological phenotyping would be considered an advantage.
The candidate should have knowledge of animal welfare regulations and ethical principles, as well as an understanding of rigorous experimental design. A careful and reproducible approach to research, combined with strong analytical and problem-solving skills, is highly important for this position. In addition, the candidate should have good written and verbal communication skills and the ability to collaborate effectively in an interdisciplinary and international research environment.
Formal certification for working with laboratory animals is highly desirable.
- A full-time, 3-year employment contract with CING;
- Salary, mobility allowance and benefits according to the applicable MSCA Doctoral Network and host-organisation rules. More detailed information about the salary will follow;
- Embedding in the international POLARIS doctoral training network;
- Access to network-wide training activities, secondments and transferable-skills development;
- A challenging and translational research project at the interface of in vivo neuroscience, rare disease biology and preclinical therapy development;
- A collaborative and entrepreneurial working environment;
- An open and supportive team culture with opportunities for scientific and professional development.
Applications for the doctoral positions have now closed. The selection process is currently ongoing, and applications are being reviewed by the recruiting institutions.
POLARIS is now moving into the next phase of its doctoral programme, which will bring together a new cohort of researchers working across disciplines and sectors to advance translational research in leukodystrophies.













